| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2010 | US20100003346 Combination methods of treating cancer |
| 01/07/2010 | US20100003338 Micelles for delivery of nitric oxide |
| 01/07/2010 | US20100003335 Microparticles for delivery to cells and/or tissue |
| 01/07/2010 | US20100003334 Combination of loteprednol etabonate and tobramycin for topical ophthalmic use |
| 01/07/2010 | US20100003332 Process For Preparing Powder Comprising Nanoparticles of Sparingly Soluble Drug |
| 01/07/2010 | US20100003331 Sustained release dosage forms of ziprasidone |
| 01/07/2010 | US20100003330 Antimicrobial nanoemulsion compositions and methods |
| 01/07/2010 | US20100003328 Bone filler for cartilage tissue regeneration treatment |
| 01/07/2010 | US20100003325 Composition and method for treatment of warts |
| 01/07/2010 | US20100003324 Vinpocetine and eburn amonine derivatives for promoting bone growth |
| 01/07/2010 | US20100003323 Hydrophilic matrix containing poorly water-soluble compound and method for producing the same |
| 01/07/2010 | US20100003322 Enteric coated hydrophobic matrix formulation |
| 01/07/2010 | US20100003321 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/07/2010 | US20100003320 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/07/2010 | US20100003319 Raloxifene immediate release tablets |
| 01/07/2010 | US20100003317 Compositions and methods for mediating rnai in vivo |
| 01/07/2010 | US20100003316 Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (pepst) and exciton-plasmon enhanced phototherapy (epep) |
| 01/07/2010 | US20100003313 Adhesive skin patch |
| 01/07/2010 | US20100003309 Method for the production of fentanyl-based anesthetics for their oral transmucosal administration in a candy-like dosage form |
| 01/07/2010 | US20100003307 Composition and use of rar antagonists for promoting chondrogenesis |
| 01/07/2010 | US20100003303 Polymers of fluorinated monomers and hydrocarbon monomers |
| 01/07/2010 | US20100003302 Vascular restenosis preventing agent and implantable intravascular device coated therewith |
| 01/07/2010 | US20100003299 RNAi Methods and Compositions for Stimulating Proliferation of Cells with Adherent Functions |
| 01/07/2010 | US20100003289 Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof |
| 01/07/2010 | US20100003287 Compositions and Methods Relating to Treatment of Cancer and Infectious Diseases |
| 01/07/2010 | US20100003280 Adjuvant compositions |
| 01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/07/2010 | US20100003268 Therapy of Malignant Neoplasias |
| 01/07/2010 | US20100003264 Reduction of Ophthalmalogic Neovascularization |
| 01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 01/07/2010 | US20100003260 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 01/07/2010 | US20100003257 Diagnosis of nasopharyngeal carcinoma and suppression of nasopharyngeal carcinoma invasion |
| 01/07/2010 | US20100003250 (2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/07/2010 | US20100003247 Assay for metastatic colorectal cancer |
| 01/07/2010 | US20100003246 Novel heterocyclic compounds and uses therof |
| 01/07/2010 | US20100003241 Agents for treatment or prevention of an allergic disorder |
| 01/07/2010 | US20100003240 Cancer treatment with endothelin receptor antagonists |
| 01/07/2010 | US20100003236 Use of c-glycoside derivatives as pro-desquamating active agents |
| 01/07/2010 | US20100003232 Insulin-degrading enzyme mutants and methods of use |
| 01/07/2010 | US20100003231 Polymers of fluorinated monomers and hydrocarbon monomers |
| 01/07/2010 | US20100003225 Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
| 01/07/2010 | US20100003224 Combination Therapy |
| 01/07/2010 | US20100003217 Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | US20100003213 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 01/07/2010 | US20100003210 External skin agent comprising modified clay for preventing inflammation |
| 01/07/2010 | US20100003208 Skin Care Products, As Well As Foods and Beverages Containing 6-O-PUFA Ascorbic Esters |
| 01/07/2010 | US20100003201 disiloxane, trisiloxane, or trialkylsilyl endcapped polysiloxanes with up to 5 repeating units, a carbomer and aqueous solution; personal care products such as cosmetics with high dispersion of carbomer |
| 01/07/2010 | US20100003193 Unit dosage of apadenoson |
| 01/07/2010 | DE102008031517A1 Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate Pyrrolopyridinyl-pyrimidin-2-yl-amine derivatives |
| 01/07/2010 | DE102008031480A1 Salze enthaltend ein Pyrimidincarbonsäure-Derivat Salts containing a pyrimidinecarboxylic derivative |
| 01/07/2010 | DE102008031284A1 Neue Bekämpfungsmöglichkeit der Giardiose New fighting chance of giardiasis |
| 01/07/2010 | DE102008031283A1 Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten New way of combating diseases caused by Trichomonadida |
| 01/07/2010 | CA2766483A1 Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers |
| 01/07/2010 | CA2764739A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 01/07/2010 | CA2761288A1 Pain-relieving compositions of furoxan no donors and uses thereof |
| 01/07/2010 | CA2731790A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
| 01/07/2010 | CA2730040A1 An intrauterine delivery system for contraception |
| 01/07/2010 | CA2729897A1 Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3-phosphate acyltransferase 1 (mtgpat1) |
| 01/07/2010 | CA2729819A1 Unit dosage of apadenoson |
| 01/07/2010 | CA2729780A1 Methods and compositions for reducing inflammation and treating inflammatory disorders |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2729757A1 Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase |
| 01/07/2010 | CA2729745A1 Oxindole compounds |
| 01/07/2010 | CA2729730A1 Use of nifurtimox for treating giardiasis |
| 01/07/2010 | CA2729727A1 Nifurtimox for treating diseases caused by trichomonadida |
| 01/07/2010 | CA2729725A1 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 01/07/2010 | CA2729720A1 Benzothiophene alkanol piperazine derivatives and their use as antidepressant |
| 01/07/2010 | CA2729710A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
| 01/07/2010 | CA2729708A1 Compounds useful for the prevention or treatment of accomodative asthenopia |
| 01/07/2010 | CA2729703A1 Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives |
| 01/07/2010 | CA2729696A1 Crystalline salts of sitagliptin |
| 01/07/2010 | CA2729690A1 Novel pyrrolo [2,3-a] carbazoles and use thereof as pim kinase inhibitors |
| 01/07/2010 | CA2729688A1 Calcium ion channel modulators & uses thereof |
| 01/07/2010 | CA2729687A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 01/07/2010 | CA2729681A1 Heterocyclic derivatives as modulators of ion channels |
| 01/07/2010 | CA2729663A1 Compounds having antiviral properties |
| 01/07/2010 | CA2729656A1 Imidazopyrimidinones and uses thereof |
| 01/07/2010 | CA2729649A1 Thiazopyrimidinones and uses thereof |
| 01/07/2010 | CA2729622A1 Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
| 01/07/2010 | CA2729620A1 Antitumoral macrolides |
| 01/07/2010 | CA2729617A1 A natural allicin tablet and preparation method thereof |
| 01/07/2010 | CA2729596A1 Melt granulation process |
| 01/07/2010 | CA2729595A1 Combinations comprising mglur modulators for the treatment of parkinson's disease |
| 01/07/2010 | CA2729582A1 Particles containing an opioid receptor antagonist and methods of use |
| 01/07/2010 | CA2729557A1 Chemical compounds 251 |
| 01/07/2010 | CA2729552A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/07/2010 | CA2729495A1 Pyrimidine derivatives as kinase inhibitors |
| 01/07/2010 | CA2729493A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/07/2010 | CA2729491A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/07/2010 | CA2729412A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | CA2729408A1 Triazole derivative or salt thereof |
| 01/07/2010 | CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 01/07/2010 | CA2729369A1 Method |
| 01/07/2010 | CA2729343A1 Topical steroidal formulations |
| 01/07/2010 | CA2729316A1 Cyclopropyl polymerase inhibitors |
| 01/07/2010 | CA2729313A1 Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists |
| 01/07/2010 | CA2729286A1 Nutritional compositions containing punicalagins |
| 01/07/2010 | CA2729253A1 Novel process |
| 01/07/2010 | CA2729246A1 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity |